VNDA
Vanda Pharmaceuticals
$5.22
+$0.04 (+0.77%)Jul 27, 2026
Key metrics
The numbers that frame VNDA today
- Market cap
- $313.91M
- P/E (TTM)
- -1.3
- EV / FCF
- -1.9
- Gross margin
- 94.2%
- EV / Sales
- 1.2
- ROIC
- -65.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $4.14
- 52wk High
- $9.94
Growth
Revenue and earnings trend for VNDA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VNDA
Is Vanda Pharmaceuticals a good buy?
Hold. Vanda Pharmaceuticals has mixed quality and weak momentum. The setup is mixed. Growth looks strong, which supports the long-term business case. We think Vanda Pharmaceuticals is selling at a very high price.
What is the market capitalization of VNDA?
Vanda Pharmaceuticals's market capitalization is $313.91M.
What is the P/E ratio for VNDA stock?
Vanda Pharmaceuticals's current P/E ratio is -1.3.
What is the 52-week high for VNDA stock?
The 52-week high for Vanda Pharmaceuticals is $9.94. The current close of $5.22 is 47.5% below that high.
What is the 52-week low for VNDA stock?
The 52-week low for Vanda Pharmaceuticals is $4.14. The current close of $5.22 is 26.1% above that low.
Does VNDA stock pay dividends?
Vanda Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VNDA?
Vanda Pharmaceuticals's Debt / Equity ratio is 0.03.